Investigation of Validity and Reliability of the Minnesota Manual Dexterity Test in Parkinson's Disease

Brief summary (registry, in English)

Parkinson's Disease (PD) is a disease that affects upper extremity functional skills with clinical findings such as bradykinesia, rigidity, and hypokinesia, and causes limitations in patients' daily life activities. The impairment of upper extremity functional skills is related to the deficiency in planning both voluntary and complex movements, as well as the deficiency in multiple motor planning. In particular; fine manual dexterity, reaching, and grasping movements are affected, greatly affecting patients' daily activities. Therefore, upper extremity evaluations are an important issue to consider for training upper extremity motor skills in PD. There are minimal assessment tools for evaluating the upper extremity functions of individuals with PD. The Nine-Hole Peg Test and the Jebsen Hand Function Evaluation Test are the most commonly used scales in the evaluation of the upper extremity in PD, and their validity and reliability have been demonstrated. These scales roughly evaluate both extremities separately. However, these scales are not suitable assessment tools for testing activities in which both extremities are frequently used in daily life. Therefore, there is a need for valid and reliable scales that can evaluate upper extremity activities both in isolation and bilaterally. The Minnesota manual dexterity test (MMDT) allows both hands to be evaluated together. It also evaluates hand-eye coordination and gross motor skills in addition to manual dexterity. MMDT is used in individuals with PD, but there is no study in the literature examining the validity and reliability of the scale. Therefore, this study aims to evaluate the reliability and validity of MMDT in individuals with PD.

What you commit to

• Study type: Observational
• Participants enrolled: 40
• From 28 Nov 2024 to the primary completion date, 10 Jan 2025
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 40 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.